mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.2 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |